Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Single-blind, Controlled Clinical Trial to Evaluate the Safety and Efficacy of PRGF-ENDORET® Infiltrations in the Treatment of Low Back Pain.

NCT06715085 is registered in ClinicalTrials.gov with Biotechnology Institute IMASD as lead sponsor.

NCT NCT06715085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06715085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Single-blind, Controlled Clinical Trial to Evaluate the Safety and Efficacy of PRGF-ENDORET® Infiltrations in the Treatment of Low Back Pain.
Lead sponsor
Biotechnology Institute IMASD
Phase
Phase 4
Overall status
Recruiting
Start date
January 23, 2025
Completion date
February 1, 2027
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diseases [c] - musculoskeletal diseases [c05